{
  "id": "telomere",
  "title": "Telomere",
  "lang": "en",
  "source_lang": "en",
  "summary": "A telomere is a specialized DNA–protein structure that protects a linear chromosome end and helps regulate chromosome stability and cellular replicative capacity.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "Chromosomal telomere"
  ],
  "generated_at": "2026-11-04",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/telomere/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/telomere/",
      "json": "https://aiwiki.page/zh/telomere.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "A telomere is a specialized structure at the end of a linear chromosome, consisting of repetitive DNA and associated proteins. Telomeres prevent natural chromosome ends from being mistaken for broken DNA and help preserve genetic information during repeated rounds of replication. They occur on the nuclear chromosomes of most eukaryotes. In humans, telomeric DNA contains many copies of the sequence TTAGGG. Telomere maintenance is important in chromosome stability, cellular aging, inherited disorders, and cancer, but telomere length alone is not a universal measure of biological age."
    },
    {
      "heading": "Structure and organization",
      "text": "Human telomeres typically contain several thousand base pairs of repetitive DNA, although their length varies substantially among individuals, tissues, and chromosome ends. The repeats are oriented so that the guanine-rich strand ends in a single-stranded 3′ overhang. Adjacent subtelomeric regions contain more variable DNA, including repetitive sequences and, in some cases, genes.\n\nThe overhang can fold back and invade the double-stranded telomeric DNA, forming a telomeric loop, or t-loop. This configuration helps conceal the physical chromosome end from cellular systems that detect DNA breaks. Telomeres are dynamic structures, however: their DNA must remain accessible to replication machinery and maintenance factors at appropriate stages of the cell cycle.\n\nIn mammals, a six-protein complex called shelterin organizes and protects telomeric DNA:\n\n- TRF1 and TRF2 bind double-stranded telomeric repeats.\n- POT1 binds the single-stranded overhang.\n- TIN2, TPP1, and RAP1 connect components or support specialized functions, including the regulation of telomere maintenance.\n\nTelomeric DNA also associates with histones and other components of chromatin. Telomeres are transcribed into telomeric repeat-containing RNA, known as TERRA, which participates in telomeric chromatin organization and maintenance.\n\nTelomere sequences and protective proteins differ among organisms. The TTAGGG repeat is widespread among vertebrates, but other eukaryotes have different repeat sequences or alternative terminal structures."
    },
    {
      "heading": "Protection of chromosome ends",
      "text": "Cells possess extensive DNA repair machinery that recognizes broken DNA and attempts to restore its continuity. A natural chromosome end presents a special problem: if treated as a break, it could be joined to another chromosome end or undergo inappropriate processing.\n\nTelomeres solve this end-protection problem by controlling access to terminal DNA and suppressing inappropriate DNA-damage signaling and repair. In mammalian cells, shelterin helps prevent both end-to-end joining and excessive processing of the overhang.\n\nWhen telomere protection fails, chromosome ends may fuse. A fused chromosome can possess two centromeres, allowing it to be pulled toward opposite poles during mitosis. Subsequent breakage can generate further rearrangements through breakage–fusion–bridge cycles. Telomere dysfunction can therefore destabilize the genome, even though normally functioning telomeres protect it.\n\nTelomere length and telomere function are related but distinct. A sufficiently short telomere may lose its protective capacity, but disruption of protective proteins can also make a relatively long telomere dysfunctional."
    },
    {
      "heading": "Replication and telomerase",
      "text": "The end-replication problem\n\nConventional DNA polymerases extend an existing DNA strand in the 5′-to-3′ direction and require a primer. During DNA replication, the lagging strand is synthesized in short fragments. Removal of the terminal primer can leave a region that cannot be copied by ordinary replication machinery. Processing required to establish the mature chromosome-end structure also contributes to terminal DNA loss.\n\nConsequently, many human somatic cell populations undergo progressive telomere shortening during repeated cell divisions. The amount lost is not constant: it depends on replication history, end processing, oxidative damage, replication stress, and the activity of maintenance pathways. Telomeric repeats are particularly challenging to replicate because of their sequence composition and capacity to form secondary structures.\n\nTelomerase\n\nTelomerase is a specialized enzyme that extends telomeric DNA. Its central components are a catalytic protein, telomerase reverse transcriptase, and an RNA molecule that supplies the template for repeat synthesis.\n\nTelomerase binds the chromosome’s 3′ end and adds telomeric repeats using its internal RNA template. Other replication factors then synthesize much of the complementary strand. Telomerase therefore counteracts terminal sequence loss rather than replacing the entire chromosome-replication machinery.\n\nIn humans, telomerase activity is tightly regulated. It is present in germline cells, early developmental cells, certain stem and progenitor populations, and some activated immune cells. Most differentiated somatic cells have insufficient activity to maintain telomere length indefinitely. Even among telomerase-positive cells, telomere length reflects a balance between extension and losses caused by replication and damage.\n\nAlternative maintenance\n\nSome cells maintain telomeres without telomerase through alternative lengthening of telomeres (ALT). This encompasses recombination-associated processes that copy telomeric DNA from other telomeric templates and involve machinery related to homologous recombination.\n\nALT is found in a minority of human cancers and in experimental cell systems. It is often associated with highly variable telomere lengths and distinctive telomeric DNA structures. It is not the usual maintenance mechanism in most human tissues."
    },
    {
      "heading": "Cellular senescence and organismal aging",
      "text": "When one or more telomeres become critically short or unprotected, they can activate a persistent DNA-damage response. In cells with intact checkpoints, this may lead to cellular senescence, a durable withdrawal from the cell cycle, or to apoptosis. Telomere shortening is therefore one mechanism that limits the replicative capacity of many cultured human cells.\n\nThe relationship between telomeres and organismal aging is more complex. Average telomere length often declines with age in human tissues, especially in cell populations that repeatedly divide. However:\n\n- Individuals differ considerably in telomere length from early life.\n- Different tissues have different replication histories and maintenance capacities.\n- The shortest or damaged telomeres can matter more than the average length.\n- Aging also involves many processes that are not reducible to telomere shortening.\n\nTelomere biology also differs across species. For example, laboratory mice generally have longer telomeres and broader somatic telomerase activity than humans, despite their much shorter lifespans. Telomere length is therefore not a simple cross-species lifespan clock."
    },
    {
      "heading": "Cancer and inherited disorders",
      "text": "Telomeres have a dual relationship with cancer. Progressive shortening can restrain tumor development by limiting cell proliferation. If growth-control checkpoints are bypassed, however, dysfunctional telomeres can promote chromosome fusions, rearrangements, and genome instability.\n\nContinued proliferation generally requires a cancer cell population to establish a telomere-maintenance mechanism. Most human cancers activate telomerase; a smaller fraction use ALT. Telomere maintenance supports sustained growth, but telomerase activation alone is not sufficient to produce cancer.\n\nInherited defects in telomere maintenance can cause telomere biology disorders. These include dyskeratosis congenita and related conditions that may involve bone marrow failure, pulmonary fibrosis, liver disease, or combinations of these manifestations. Disease-associated variants occur in genes encoding telomerase components, telomerase-assembly factors, and other proteins required for telomere replication and protection.\n\nClinical manifestations and age of onset vary considerably. Some affected families show genetic anticipation, in which disease appears earlier or more severely in successive generations, partly because shortened telomeres can be inherited alongside a maintenance defect."
    },
    {
      "heading": "Measurement and interpretation",
      "text": "Several methods measure telomere length or maintenance activity, but they provide different kinds of information:\n\nMethod | Main information obtained | Important limitation\nTerminal restriction fragment analysis | Distribution of telomere-associated DNA fragment lengths | Includes some subtelomeric sequence and usually requires substantial DNA\nQuantitative [[polymerase-chain-reaction | polymerase chain reaction]] | Relative abundance of telomeric repeats compared with a reference sequence\nQuantitative fluorescence in situ hybridization | Fluorescence-based estimates for individual chromosome ends or cells | Requires calibration and careful sample preparation\nFlow-FISH | Telomeric fluorescence in defined cell populations using [[flow-cytometry | flow cytometry]]\nSingle-telomere and shortest-telomere assays | Length distributions at particular ends or among very short telomeres | Different assays capture different subsets of telomeres\n\nMeasurements of telomerase activity are separate from measurements of telomere length: an enzyme-activity result does not directly establish the lengths or protective state of chromosome ends.\n\nBlood-based measurements usually concern white blood cells rather than every tissue in the body. Differences in blood-cell composition, DNA preparation, assay design, and reference populations can influence results. Average leukocyte telomere length is studied as a biomarker, but it does not by itself establish an individual’s biological age or predict a specific health outcome."
    },
    {
      "heading": "Historical development",
      "text": "In the 1930s, Hermann J. Muller and Barbara McClintock independently established that natural chromosome ends behave differently from broken chromosome ends. Muller introduced the term telomere, derived from Greek words meaning “end” and “part.”\n\nIn the early 1970s, Alexey Olovnikov and James Watson independently discussed difficulties in fully replicating the ends of linear DNA. These ideas helped connect chromosome-end biology with limits on cellular replication.\n\nElizabeth Blackburn and Joseph Gall identified repeated terminal DNA sequences in the ciliate Tetrahymena in the late 1970s. Blackburn and Jack Szostak subsequently showed that these sequences could protect chromosome ends in yeast. Carol Greider and Blackburn discovered telomerase activity in 1984 and published the finding in 1985.\n\nBlackburn, Greider, and Szostak received the 2009 Nobel Prize in Physiology or Medicine for discovering how chromosomes are protected by telomeres and telomerase."
    }
  ],
  "links": [
    "chromosome",
    "dna",
    "protein",
    "eukaryote",
    "cancer",
    "cell-cycle",
    "histone",
    "chromatin",
    "dna-repair",
    "centromere",
    "mitosis",
    "genome",
    "dna-polymerase",
    "dna-replication",
    "cell-division",
    "telomerase",
    "enzyme",
    "rna",
    "homologous-recombination",
    "apoptosis",
    "polymerase-chain-reaction",
    "flow-cytometry",
    "biomarker"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}